Platelets (Nov 2021)

Hiding in plain sight – platelets, the silent carriers of HIV-1

  • Yvonne Baumer,
  • Tina M. Weatherby,
  • Brooks I. Mitchell,
  • Ivo N. SahBandar,
  • Thomas A. Premeaux,
  • D’Antoni Michelle L.,
  • Cristhian A. Gutierrez-Huerta,
  • Tiffany M. Powell-Wiley,
  • Timothy R. Brown,
  • William A. Boisvert,
  • Cecilia M. Shikuma,
  • Lishomwa C. Ndhlovu

DOI
https://doi.org/10.1080/09537104.2020.1849606
Journal volume & issue
Vol. 32, no. 8
pp. 1038 – 1042

Abstract

Read online

There are approximately 38 million people globally living with Human immunodeficiency virus 1 (HIV-1) and given the tremendous success of combination antiretroviral therapy (cART) this has dramatically reduced mortality and morbidity with prevention benefits. However, HIV-1 persists during cART within the human body and re-appears upon cART interruption. This HIV-1 reservoir remains a barrier to cure with cellular sites of viral persistence not fully understood. In this study we provide evidence corroborating a recently published article in STM demonstrating the role of platelets as a novel cellular disseminator of HIV-1 particles in the setting of viral suppression. Using classical transmission electron microscopy with and without immunogold labeling, we visualize HIV-1 in both platelets and monocytes in cART suppressed HIV donors. Our study suggests that due to the close proximity of platelets and monocytes an alternative life cycle of HIV-1 cycling within monocytes and platelets without the need of active replication under cART occurs. Our findings are supported by the lack of detectable HIV-1 particles in platelets derived from HIV uninfected donors or the ‘Berlin’ patient suggesting that platelets may serve as an underappreciated hidden bearer for HIV-1 and should be considered in HIV remission studies and trials.

Keywords